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Measurement of areal bone mineral density (aBMD) in intra-vertebral subregions may increase the 
diagnostic sensitivity of dual energy X-ray absorptiometry (DXA)-derived parameters for vertebral 
fragility. This study investigated whether DXA-derived bone parameters in vertebral subregions were 
better predictors of vertebral bone strength in specimens with low aBMD, compared to those with 
higher aBMD.  
Twenty-five lumbar vertebrae (15 embalmed, 10 fresh-frozen) were scanned with postero-anterior 
(PA) and lateral-projection DXA and then mechanically tested in compression to ultimate failure. 
Whole-vertebral aBMD and bone mineral content (BMC) were measured from the PA- and lateral-
projection scans and within 6 intra-vertebral subregions. Multivariate regression was used to predict 
ultimate failure load by BMC, adjusted for vertebral size and specimen fixation status across the 
whole specimen set, and when sub-grouped into specimens with low aBMD and high aBMD. 
Adjusted BMC explained a substantial proportion of variance in ultimate vertebral load when 
measured over the whole vertebral area in lateral projection (adjusted R2: 0.84) and across the six 
subregions (ROIs 2-7) (adjusted R2 range: 0.58-0.78). The association between adjusted BMC, either 
measured subregionally or across the whole vertebral area, and vertebral failure load, was increased 
for the subgroup of specimens with identified “low aBMD”, compared to those with “high aBMD”, 
particularly in the anterior subregion where the adjusted R2 differed by 0.44. 
The relative contribution of BMC measured in vertebral subregions to ultimate failure load is greater 
among specimens with lower aBMD, compared to those with higher aBMD, particularly in the 
anterior subregion of the vertebral body. 







It is well established that bone microstructure and quantity are distributed heterogeneously 
throughout the vertebral body [1-8] and that variance in these distributions influences bone 
strength [9-11,7,8], and responses to bisphosphonate therapy [12]. The intra-vertebral distribution 
of bone microstructure and quantity is therefore likely to have important implications for the 
mechanisms underlying vertebral fracture [13-16]. We have previously undertaken research to 
establish the precision and accuracy of a subregional bone mineral density (srBMD) method [2,3,6] 
and its application in the clinical setting [14,17]. Comparing differences in srBMD values between 
individuals may be confounded by the variability in their bone size. However, this variability can be 
overcome by comparing the ratios of srBMD values (that is the ratio of one subregion to another 
within the same vertebral body) among individuals, rather than their absolute aBMD values. Using 
ratios of srBMD to compare between individuals removes the potentially confounding influence of 
differences in the sizes of the vertebrae, and as such of the subregions, between individuals. Our 
preliminary clinical data suggest that there is little difference in the ratios of srBMD between 
individuals with normal areal bone mineral density (aBMD) and those with primary osteoporosis, 
inferring there is a general, homogeneous vertebral bone loss associated with primary osteoporosis, 
not confined to a preferential subregional area within the vertebra. However, we have observed 
selective subregional bone loss among individuals with glucocorticoid-induced osteoporosis (GIO) 
[17], which may suggest selective subregional vertebral bone loss in specific disease states, such as 
in GIO, or a change in selectivity in individuals with advanced disease state. It is warranted, 
therefore, to explore the contribution of subregional vertebral bone mineral measures in predicting 
vertebral failure in differing states of vertebral bone loss.  
 
While generally less precise than postero-anterior (PA)-projection scans, bone mineral 
measurements derived from lateral-projection scans may have the potential to improve fracture 
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prediction estimates. Despite the general low acceptance of lateral-projection scanning, largely 
attributed to poorer precision and relative lack of reference data, a web of evidence points to the 
potential clinical utility of bone mineral data derived from lateral-projection scans compared to PA-
projection scans, including a stronger association with vertebral failure strength [18,19], superior 
diagnostic sensitivity [20,21,14,22,23] and greater sensitivity to changes in bone mineral 
measurements with therapy [24-27] or ageing [21]. However, despite greater sensitivity to changes 
in bone mineral measurements with therapy, Blake et al [24] concluded that PA-projection measures 
are the most suitable for longitudinal studies. Further, Bjarnason et al [28] also identified that while 
lateral projection scanning had a diagnostic advantage in vitro, consistent with more recent data 
[19,18], this diagnostic advantage was not sustained in situ due to a lower ratio of bone to soft tissue 
in the lateral projection mode.  Ultimately, the choice of scanning projection revolves around the 
balance between sensitivity in fracture prediction on the one hand and measurement precision on 
the other.  For example, an added advantage of the lateral-projection approach is the ability to 
measure aBMD in vertebral subregions [2,3], which may improve measurement specificity for DXA, 
and ultimately improve fracture risk prediction [3], particularly in patients with GIO [17].  In this 
study we have chosen to explore whether sensitivity can be enhanced by using subregional bone 
mineral measures derived from lateral projection scans. If successful, this methodological 
development could lead to a re-appraisal of the diagnostic utility of lateral spine scanning.  
 
The aim of this study was to examine the relationship between subregional bone mineral content 
(BMC) derived from lateral-projection DXA from human cadaveric spine specimens and vertebral 
failure strength determined experimentally. We hypothesised that, in vertebrae with more advanced 
bone loss, subregional BMC measurements would more strongly  predict vertebral body strength 




2. Materials and Methods 
2.1 Specimens 
The imaging and mechanical testing procedures used in this study have been reported in detail 
elsewhere [2,3,18], and are described briefly below. Twenty-five vertebral bodies (L2-L4), derived 
from a set of 10 embalmed and 5 fresh-frozen cadaver spines (7 male, 8 female; mean (SD) age at 
death 78.2 (9.6) years), were available for analysis in this study (Table 1). The 10 embalmed donor 
cadavers were fixed with 20-40 L of embalming fluid (55% ethanol, 5% formaldehyde, 5% phenol, 
20% propylene glycol and 15% water) and stored at 4C for 3 months prior to harvesting of the 
spine. Previous investigators have found no effect of formalin fixation on vertebral BMD estimations 
by DXA on embalmed specimens compared to fresh specimens [29]. Therefore, data derived from 
fresh and embalmed specimens were pooled when examining vertebral bone mineral distributions 
across the sample (see data analysis section 2.5). The 5 fresh-frozen specimens were frozen at -17 
°C. In all specimens, the ribs and ilia were removed from the spine segments leaving intact vertebral 
bodies and connective tissues. Embalmed specimens were sealed in water-tight shrink-wrap 
thermoplastic while fresh-frozen specimens remained in gauze wrap. Prior to any scanning, lateral 
radiographs were acquired from each specimen to screen for vertebral fractures and any other overt 
bone pathology and to verify vertebral levels in conjunction with a PA-projection DXA image. Fresh-
frozen specimens were scanned in a frozen state, removed from the freezer just before the 
commencement of scanning. The cadavers used in this study were donated by the next-of-kin of the 
deceased for use in medical research under the terms and conditions contained within the Anatomy 
Act of South Australia. The specific terms that apply to this study are that the research be approved 
by the institutional research committees. Approval to use the specimens for research purposes was 
granted by the Human Research Ethics Committee at the Royal Adelaide Hospital, South Australia, 
and Curtin University, Western Australia. 
Each specimen was scanned using DXA and subsequently mechanically tested to failure. 
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2.2 Dual energy X-ray absorptiometry (DXA) 
All scanning was performed using a Hologic (Hologic Inc., Bedford, MA; USA) QDR4500A fan beam 
densitometer, with a spatial resolution of 1.0 mm, running operating software version 9.10D. Spine 
samples were placed supine in a water bath (270180150mm) of tap water to a depth of 18cm to 
simulate soft tissue composition in vivo. This procedure has been used in previous ex vivo studies 
with validity and reliability established for both lumbar and thoracic vertebrae [30,19,31-33]. A 
matched PA-supine lateral scan pair was acquired on each specimen using the array scanning mode. 
Each lateral scan was performed with a fixed scan length of 15.32 cm and width of 14.47 cm and 
pixel size of 1.007 mm. At the completion of the lateral scan, both a standard analysis and a 
customised subregional analysis were performed. Areal BMD was calculated for the whole vertebral 
body area (defined as region of interest (ROI) 1) and within six subregions: three oriented sagittally 
(ROIs 2-4) and three transversely (ROIs 5-7) (Figure 1). Subregions were created manually by 
modifying the regions of interest during the analysis phase. The whole vertebral area (ROI 1) was 
defined by the four corners of the vertebra of interest from the lateral DXA image, including the 
vertebral endplate and excluding the posterior elements. Overt osteophytes were excluded from the 
ROIs and deleted from the bone map manually, in agreement with previous work [31,34,35]. The 
size and shape of ROI 1 was defined according to the morphology of the vertebral body. The 
endplates defined the superior and inferior margins, the anterior border of the centrum defined the 
anterior margin, while the posterior margin was defined by the junction between the vertebral 
centrum and pedicle of the posterior elements. Subregions 2-4 formed equal thirds in the area of 
ROI 1, oriented sagittally. Subregions 5-7 formed equal thirds in area of ROI 1, oriented transversely. 
Our pilot data demonstrate good to fair short-term precision of this protocol when applied at L2 and 
L3 ex vivo (% CV range 1.8-6.8%) [36]. We have also established acceptable precision of the 




2.3 Measurement of vertebral geometry 
Absolute vertebral height was measured by digitising vertebral dimensions visible on the lateral DXA 
scan. Digital images of the lateral DXA scan were imported into image processing software (Image J 
version 1.30, National Institute of Health, Maryland, USA). Images were digitised to extract Cartesian 
x,y coordinates of corners of each vertebral body. After correcting for rotation, x,y coordinates were 
transformed into real dimensional units (cm) to determine vertebral height. 
 
2.4 Mechanical testing 
After DXA scanning, the vertebral bodies were mechanically tested to failure. The specimen 
preparation and testing procedure was performed based on previously published protocols 
[37,18,38]. On both the endplates, a 3mm-thick layer of polymethylmethacrylate (PMMA) was 
applied, by submerging the vertebra into a curing PMMA mixture. The specimens were soaked for 12 
hrs in saline solution at room temperature for rehydration [19,18], before being placed in the 
mechanical testing machine (Model 800L, TestResources Inc, Shakopee, MN, USA). The uniaxial 
compression tests were performed between steel platens with a lockable ball joint to ensure plano-
parallel ends [37]. A saline-soaked gauze was used to keep the specimens moist during the 
experiment, which was done at room temperature. After preconditioning (5 cycles, at 0.1Hz, 
between 150N and 350N, then held at 250N for 5 minutes), the specimens were tested in 
displacement control at a rate of 0.15mm/s [38,37,18]. The displacement was measured by a 
transducer (Linear Variable Differential Transformer) attached to the cross-head. Vertebral body 
strength (Fult, expressed in kN) was defined as the peak load during the compressive loading (i.e. the 
ultimate load). The compressive stiffness (kN/mm) was also calculated, as the slope of the linear 
portion of the load-displacement curve, between 25% and 75% of the failure load [39]. The 
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deformation to failure was calculated from the load-displacement curve, by extrapolating the linear 
elastic portion back to zero load and expressed as a percentage of the original specimen height.  
 
2.5 Data analysis 
Descriptive statistics were used to summarise specimen densitometric characteristics and 
mechanical properties. Mechanical properties were compared between embalmed and fresh-frozen 
specimens using a one-way ANOVA, including models where parameters were adjusted for vertebral 
height. A repeated measures ANOVA was performed to evaluate differences in aBMD and BMC 
between subregions, in keeping with earlier work [30,14,3,17,2]. Given this was a within-specimen 
analysis and that fixation does not influence DXA-measured BMD [29], data from embalmed and 
fresh-frozen specimens were pooled in the ANOVA models, as performed previously [2]. While there 
were seven regions of interest (ROIs), the within-subject factor (ROI) was set a priori at k=4 to ensure 
that overlapping subregions were not compared post hoc. That is, sagitally-oriented subregions were 
not compared with transversely oriented subregions in the same ANOVA model. Therefore, the first 
ANOVA model included ROIs 1-4 and the second ANOVA model included ROIs 1 and 5-7. Bonferroni 
adjustments were applied to pairwise comparisons to account for multiple tests. Multivariate 
regression models were used to quantify the association between ultimate vertebral failure load 
(dependent variable) and BMC (predictor variable), adjusted for vertebral height and specimen 
fixation status. Vertebral height was included in the model as an index of vertebral size, as it is a 
relatively simple measurement and can be directly measured from DXA scans [3] and has been used 
previously in multiple regression models for this purpose [40]. Due to the inclusion of an index of 
vertebral size in the regression models, BMC, rather than aBMD, was used as the predictor variable.  
While formalin fixation does not appear to systematically affect bone mineral measurements, it has 
been shown to  influence compressive strength of vertebral bone [29]. Hence, specimen fixation 
status was included as a nominal variable in multiple regression models. Multivariate models were 
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run for a pooled sample of 25 vertebrae and for two sub-groups of vertebrae categorised as “low 
aBMD (n=13)” and “high aBMD (n=12)”, based on a median split of lateral-projection aBMD values of 
the ROI 1 at 0.458 g/cm2. The aBMD data calculated for ROI 1 were normally distributed.  For all 
regression models, adjusted R2 values were used as the index to quantify strength of association. 
Data were analysed using IBM SPSS Statistics 19, IBM Corporation. 
 
3. Results 
3.1 Descriptive characteristics 
Standard, whole vertebral aBMD was not significantly different between 15 embalmed and 10 fresh-
frozen lumbar vertebrae in either the PA [mean (SD): 0.80 (0.17) g/cm2 and 0.90 (0.14) g/cm2, 
respectively; mean difference [95% CI] -0.1 [-0.23, 0.04] g/cm2] or lateral projections [0.47 (0.12) 
g/cm2 and 0.54 (0.11) g/cm2, respectively; -0.07 [-0.16, 0.03] g/cm2]. A similar finding was observed 
for whole vertebral BMC in the PA [12.6 (4.0) g and 14.0 (4.0) g, respectively; -1.5 [-4.9, 1.9] g) and 
lateral (4.8 (2.1) g and 5.6 (1.8) g, respectively; -0.8 [-2.5, 0.9] g] projections. 
3.2 Subregional aBMD and BMC profiles 
A main effect for ROI was observed when comparing aBMD and BMC between sagittal and 
transverse ROIs (p<0.0001). In the sagittal ROI analysis, a significant difference was observed 
between all ROIs for aBMD (p≤0.004; Figure 2) and BMC (p<0.0001; Figure 3). The highest aBMD was 
observed in the posterior subregion (ROI 2), while the lowest aBMD was observed in the anterior 
subregion (ROI 4). When considering the intra-vertebral subregions only, the same distribution 
pattern was observed for BMC profiles. In the transverse ROI analysis, a significant difference was 
observed between all ROIs for aBMD (p≤0.006; Figure 2), other than between whole (ROI 1) and 
superior (ROI 5) regions (p=0.11). For BMC, a significant difference was observed between all 
subregions (p≤0.0001; Figure 3), other than between the superior (ROI 5) and inferior (ROI 7) 
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subregions. The highest aBMD was observed in the inferior subregion (ROI 7), while the lowest 
aBMD was observed in the central subregion (ROI 6).  
3.3 BMC as a predictor of ultimate vertebral failure 
Table 2 provides a summary of mechanical parameters measured. Mean ultimate vertebral failure 
load (Fult) and vertebral height-adjusted mean ultimate failure load did not exhibit statistically 
significant differences between embalmed and fresh-frozen specimens. Mean vertebral stiffness was 
significantly higher and mean relative ultimate deformation significantly lower, in embalmed 
specimens.  
 
Multivariate regression models with adjusted BMC as the predictor, explained a substantial 
proportion of variance in ultimate vertebral load where BMC was measured over the whole 
vertebral area in lateral projection (ROI 1; adjusted R2: 0.84) and across the six subregions (ROIs 2-7) 
(adjusted R2 range: 0.58-0.80; p<0.0001). BMC derived from lateral-projection DXA, measured across 
the whole vertebral area (ROI 1) or within a subregion (ROIs 2-7), accounted for a substantially 
greater proportion of variance in ultimate load, compared to BMC derived from PA-projection (Table 
2).  Both vertebral height and fixation status remained significant co-variates across most 
multivariate models, other than the high aBMD subgroup where vertebral height was not a 
significant predictor of failure load (Table 3).  
 
Across all the specimens, subregional BMC (ROIs 2-7) was not a stronger predictor of ultimate 
vertebral failure load than BMC measured across the whole vertebral area (ROI 1) (Table 3). 
However, when analysed in aBMD subgroups, subregional BMC accounted for a greater proportion 
of variance in ultimate vertebral failure load in the low aBMD subgroup, compared to the high aBMD 
subgroup (mean increase in variance explained: 18%). This was particularly noticeable for the change 
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in adjusted R2 at ROIs 4, 6, and 7, where the adjusted R2 values increased by 0.44, 0.15, and 0.24, 
respectively, compared to the high aBMD group (Figure 4). Within the low aBMD subgroup, BMC 
measured at ROIs 4 and 7 explained a greater proportion of variance in ultimate vertebral load, than 
BMC measured at ROI 1, although not by a clinically meaningful amount. Similar to the multivariate 
regression models using the whole dataset, measures of BMC derived from lateral projection DXA, 
either whole vertebral (ROI 1) or subregional (ROIs 2-7), explained a greater proportion of variance 
in ultimate load than BMC derived from PA-projection DXA (Table 3). 
 
4. Discussion 
Consistent with previous investigations, this study confirms that vertebral aBMD and BMC measured 
by lateral-projection DXA vary within the vertebral body [13,22,3]. In accordance with existing 
literature [33,18,19,41], BMC was found to be a strong predictor of ultimate vertebral failure load, 
and a substantially greater proportion of variance in failure load could be explained by BMC when 
measured using lateral-projection DXA, compared with PA-projection DXA (e.g., R2=0.86  vs. 0.57).  
This finding supports the potential for broader application of lateral-projection DXA in clinical 
settings. Moreover, when subgrouping our cohort into vertebrae with lower and higher aBMD, 
variations in vertebral failure load were better explained by adjusted BMC values for specimens with 
lower aBMD. In particular for subregional BMC measures, vertebrae with lower aBMD exhibited 
stronger correlations (R2 up to 0.88) with failure load, compared to vertebrae with higher aBMD (R2 
up to 0.72). Although, when compared to lateral BMC measures derived from the whole vertebral 
body (R2= 0.84), the increase in R2 value due to subregional BMC measures unlikely represents a 
clinically-meaningful improvement in magnitude, our data highlight the potential biological and 





Differences in aBMD and BMC between subregions demonstrated in this study are comparable to 
those we have observed in clinical [6,17] and ex vivo [30] studies previously. It is most likely that the 
patterns of distribution of subregional bone mineral properties influence the mechanical behaviour 
of the vertebral body, particularly the relative distributions between subregions. For example, DXA-
derived aBMD and BMC are lower in the anterior and central subregions, compared to other regions 
such as the posterior region and regions adjacent to the endplates. This observation is likely due to 
the relatively lower amount of bone present in these regions, particularly in the central region (ROI 
6) as shown in our previous studies including using pQCT [22,3] and may point to a mechanism 
underlying vertebral anterior wedge fractures [42]. The profiles of subregional aBMD and BMC 
appear to be consistent across ex vivo studies [2,14], consistent across imaging modalities [3], and 
consistent between individuals with normal aBMD and BMC and those with primary osteoporosis, 
suggesting non-selective vertebral bone loss. We demonstrated recently that the vertebral 
subregional aBMD distribution profile appears to differ among individuals with GIO [17], suggesting 
selective vertebral bone loss in specific vertebral subregions, particularly ROI 4. Although this finding 
needs verification in larger studies with multiple patient groups, it does provide a rationale that 
subregional bone distribution measured by DXA may have important biological significance to 
vertebral strength in specific patient groups, and/or in vertebrae with advanced bone loss. Indeed, 
the results from this study highlight that subregional BMC is a stronger predictor of vertebral failure 
load in a group of specimens presenting with lower aBMD values compared to specimens with high 
aBMD. This finding was particularly evident in the anterior subregion, where a further 44% of 
variance in failure load was explained in samples with low aBMD compared to high aBMD.  The 
strong relationship between BMC measured in the anterior subregion with vertebral failure load in 
specimens with low aBMD is likely related to the extent of intervertebral disc degeneration. Earlier 
studies have demonstrated an association between disc degeneration and relative increased bone 
loss in the anterior region of the vertebral body [5,42], which is likely to lead to increased propensity 
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to vertebral body failure. We are unable to speculate further on these associations as we have no 
data regarding disc degeneration in our specimen sample.  However, this represents an important 
consideration for future research. 
 
While we acknowledge that the proportion of variance explained by subregional measures of BMC 
(ROI 4) was only up to 4% greater than that explained by BMC measured from the whole vertebral 
body, the finding is consistent with previous work [9]. Moreover, the difference in R2 values between 
multivariate models using high aBMD samples compared to low aBMD samples was substantially 
greater for the subregions (0.03-0.44), compared to the whole vertebral BMC (0.11), demonstrating 
an increasing contribution of subregional BMC to influencing vertebral failure as bone loss 
progresses. Here, the relative importance of subregional bone mineral measures may be related to 
progressively selective bone loss [43], influenced for example, through intervertebral disc 
degeneration [5]. 
 
Our data suggest that BMC measured in the superior and inferior ROIs  (ROIs 5 and 7) has a more 
substantial role in determining vertebral strength in uniaxial compressive testing, compared to BMC 
derived from the central ROI (ROI 6), pointing to a critical role of the bone in the superior and 
inferior zones of the vertebral body  in modulating vertebral failure in compression.  This 
observation was consistent across specimens with high and low aBMD and concurs with results from 
CT-based finite element modelling by Eswaran et al [44] and  Homminga et al [45].  
 
This study had several important strengths. First, although the likely importance of subregional bone 
mineral properties in modulating vertebral failure load has been noted previously for BMD [9] and 
bone volume fraction [10] particularly in the anterior region, measurements of bone mineral 
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properties in this area using DXA and linking them to failure load have not previously been explored. 
Second, we mechanically tested a large sample of vertebrae which allowed us to undertake sub-
group analyses based on a median split of aBMD values. Third, we examined the association 
between failure load and BMC using multivariate models, accounting for the potentially confounding 
influence of specimen fixation and vertebral size. Moreover, the standardised regression coefficients 
reported in this study are comparable to those reported previously by Edmondston et al [40]. Some 
important limitations should be considered in the interpretation of our results. First, the loading 
condition we applied to the vertebrae is not completely representative of physiologic conditions. 
Although compression in inferior-superior direction is the predominant loading direction in upright 
stance on the lumbar spine [46], the experimental protocol used in the study does not account for 
other forces or moments the vertebrae would experience in vivo, such as bending moments. More 
importantly, the significant role of the intervertebral disc in transferring load across the vertebral 
body is not considered in our protocol, nor the influence of disc degeneration on load transmission 
across the vertebral body and the likely secondary consequences of altered load transmission on 
subregional bone mineral properties [5,42,47]. Second, we chose to employ DXA as the imaging 
modality in this study owing to its ubiquitous use in the clinical environment. Consequently, our 
inferences regarding the relationship between BMC and load are limited to composite measures of 
trabecular and cortical bone and do not enable us to explore the important contributions of these 
bone components independently [18], or the contribution of subregional bone micro-architecture to 
mechanical behaviour [39]. Further, matched PA-lateral scans are only available with Hologic 
densitometers. While other manufacturers enable acquisition of lateral-projection scans, a decubitus 
position is generally required which is associated with unacceptably low precision and substantially 
longer operator time. Third, the experimental protocol involving a water bath to acquire DXA scans 
does not truly correspond with the clinical environment where scan artefacts attributed to variance 
in soft tissue composition of the trunk and arterial calcification are commonplace.  Finally, when 
considering our pooled sample of 15 donors, the mean PA-projection derived aBMD values 
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represent that of an aged population with increased risk of fracture, reflecting osteoporosis (males: 
mean[sd] aBMD=0.781 [0.142] g/cm2; females: 0.725 [0.185] g/cm2), based on the aBMD values 
reported by Henry et al [48] (average values below −2.5 SD).  When sub-grouped, donors in the low 
aBMD fell in the osteoporosis range (PA aBMD values below −2.5 SD), while those in the high aBMD 
fell in the osteopenic range (PA aBMD values between -1 and -2.5 SD). This, together with the 
advanced age, suggests that subjects sampled in our study might generally represent a subgroup 
with an increased risk of fracture compared to the normal population. Importantly, these estimates 
have been calculated by adjusting our raw data for scanner type [49] and for data derived from ex-
situ scanning where values are recommended to be lowered by 10% to be compared to in-situ 
scanning [50], consistent with an approach we have reported previously [18]. 
 
Given the expanding web of knowledge surrounding the potential biological significance of 
measuring subregional bone mineral properties with lateral-projection DXA, it will now be important 
to verify lab-based findings with further clinical studies to elucidate changes in subregional bone 
properties over time and in response to therapies. It will also be important to verify the associations 
between subregional bone mineral properties and mechanical behaviour of whole vertebral bone 
using experimental loading conditions which more closely replicate physiologic loading. Ultimately, 
clinical studies that compare fracture prediction by different DXA modalities will be important.  
 
5. Conclusion 
BMC measured from lateral-projection DXA, either across the whole vertebral area or within 
vertebral subregions, is a stronger predictor of failure load than BMC measured from PA-projection 
DXA. The relative contribution of BMC measured in vertebral subregions to ultimate failure load is 
substantially greater among specimens with lower global aBMD, particularly in the anterior 
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subregion of the vertebral body, as opposed to those with high aBMD. In specimens with low aBMD, 
BMC measured from the anterior subregion accounts for a slightly greater proportion of variance in 
vertebral failure load than a measure of whole vertebral BMC. 
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Table 1  Summary of specimens used in this study by gender 
Vertebral level Embalmed (n=10 donors) Fresh-frozen (n=5 donors) 
L2 4 male, 3 female 2 male, 1 female 
L3 3 male, 5 female 2 male, 3 female 
L4 0 2 female 

















Table 2 Summary of mechanical data measured in embalmed (n=15) and fresh-frozen (n=10) vertebrae expressed as mean (SD). The mean 
difference and 95% confidence interval (CI) are provided for the unadjusted difference, and vertebral height-adjusted difference. 
Mechanical parameter Embalmed  Fresh-frozen Mean difference (95% CI) Adjusted mean difference (95% CI) 
Ultimate load (Fult) (kN) 5.00 (2.28) 3.83 (1.40) 1.17 (-0.50, 2.84) 1.09 (-0.62, 2.81) 
Stiffness (kN/mm) 8.52 (3.43) 5.05 (1.86)^ 3.46 (1.00, 5.93)^ 3.23 (0.78, 5.69)
^ 
Relative ultimate deformation (%) 2.21 (0.43) 3.46 (1.08)^ -1.24 (-1.88, -0.61)^ n/a 







Table 3: Multivariate regression model results for each vertebral region of interest (ROI), 
analysed as a pooled data set (n=25) and by low aBMD (n=13) and high aBMD (n=12) 
subgroups. The proportion of variance in the dependent variable (failure load) 
explained by the predictor variable (BMC), adjusted for vertebral height and fixation, 
is expressed as the R2 parameter. Standardised regression coefficients for each 
component of the multivariate model indicate the relative contribution of each 
component in explaining the total variance in the dependent variable. 
    










Pooled       
 
1 0.86 0.84 1.06 -0.40 -0.66 
 
2 0.81 0.78 0.97 -0.28 -0.62 
 
3 0.81 0.78 0.99 -0.32 -0.61 
 
4 0.67 0.63 0.99 -0.44 -0.65 
 
5 0.79 0.76 1.01 -0.34 -0.67 
 
6 0.63 0.58 0.86 -0.21a -0.63 
 
7 0.82 0.8 1.02 -0.41 -0.54 
 
PA-projection 0.57 0.51 0.73 -0.10a -0.44 
Low aBMD sub-groupc 
      
 
1 0.88 0.83 0.66 -0.46 -0.66 
 
2 0.83 0.77 0.63 -0.44 -0.63 
 
3 0.81 0.75 0.62 -0.55 -0.8 
 
4 0.91 0.88 0.70 -0.38 -0.54 
 
5 0.83 0.77 0.63 -0.48 -0.65 
 
6 0.75 0.66 0.59 -0.68 -0.86 
 
7 0.88 0.84 0.69 -0.35 -0.52 
 





High aBMD sub-groupd 
      
 
1 0.80 0.72 0.89 -0.35a -0.73 
 
2 0.75 0.66 0.69 -0.13a -0.73 
 














6 0.64 0.51 0.39a 0.16a -0.68 
 














a: variable not a significant predictor in multivariate model (p>0.05) 
b: multivariate model not significant (p>0.05) 
c: sub-group defined by median split of aBMD data measured at ROI 1 (≤0.458 g/cm2; n=13) 
d: sub-group defined by median split of aBMD data measured at ROI 1 (>0.458 g/cm2; n=12) 




Figure 1: DXA-derived vertebral subregions defined using Hologic software. ROI 1 (whole) was 
defined by the four corners of the vertebra. ROIs 2-4 (posterior, middle, anterior) 
formed equal thirds in the area of ROI 1, oriented sagittally. ROIs 5-7 (superior, 
central, inferior) formed equal thirds in area of ROI 1, oriented transversely. 
Reproduced from the Journal of Clinical Densitometry, Vol 13, Briggs et al., “Novel 
assessment of subregional bone mineral density using DXA and pQCT, and 
subregional micro-architecture using micro-CT in whole human vertebrae: 
Applications, methods, and correspondence between technologies”, pp. 161-174, 
Copyright (2010), with permission from Elsevier Copyright Clearance Center. 
Figure 2: Mean areal bone mineral density (aBMD; g/cm2) measured across the whole 
vertebral area (ROI 1) and in the six intra-vertebral subregions (ROIs 2-7). Error bars 
denote standard error. All pairwise comparisons are Bonferroni corrected 
(p≤0.006): 
a: significantly different to ROI 1 (whole); b: significantly different to ROI 2 
(posterior); c: significantly different to ROI 3 (middle); d: significantly different to ROI 
4 (anterior); e: significantly different to ROI 5 (superior); f: significantly different to 
ROI 6 (central); g: significantly different to ROI 7 (inferior). 
Figure 3: Mean bone mineral content (BMC; g) measured across the whole vertebral area (ROI 
1) and in the six intra-vertebral subregions (ROIs 2-7). Error bars denote standard 
error. All pairwise comparisons are Bonferroni corrected (p≤0.0001): 
a: significantly different to ROI 1 (whole); b: significantly different to ROI 2 
(posterior); c: significantly different to ROI 3 (middle); d: significantly different to ROI 
4 (anterior); e: significantly different to ROI 5 (superior); f: significantly different to 




Figure 4: Scatterplots illustrating multivariate regression-standardised predicted ultimate 
vertebral failure load (y axis) against value of experimentally measured ultimate 
vertebral failure load (x axis), in high and low aBMD sub-group analyses for ROI 4 (A 
and B, respectively), ROI 6 (C and D, respectively) and ROI 7 (E and F, respectively). 
Each panel displays the unadjusted R2 value and the linear regression line of best fit 
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